name: Anastomosis of left internal thoracic artery to third obtuse marginal branch of circumflex branch of left coronary artery


name: Prescription of parenteral nutrition feeding


name: Prescription of enteral nutrition feeding


name: Direct laryngoscopy with operating microscope


name: Hydrochlorothiazide- and nebivolol-containing product


name: Hydrochlorothiazide and nebivolol only product


name: Hydrochlorothiazide and nebivolol only product in oral dose form


name: Atorvastatin- and fenofibrate-containing product


name: Atorvastatin and fenofibrate only product


name: Atorvastatin and fenofibrate only product in oral dose form


name: Percutaneous cryoablation of lesion of adrenal gland


name: High intensity focused ultrasound ablation of thyroid


name: Percutaneous coronary intervention of intermediate artery of left main coronary artery


name: Partial replacement of joint of bilateral shoulder regions


name: Percutaneous coronary intervention on ostial left main coronary artery


name: Endoscopic ultrasonography guided biopsy of bile duct


name: Endoscopic ultrasonography guided biopsy of colon


name: Endoscopic ultrasonography guided biopsy of lesion of bile duct


name: Laparoscopic ultrasonography guided biopsy of lesion of bile duct


name: Laparoscopic adrenalectomy using robotic assistance


name: Levamlodipine only product in oral dose form


name: Dicyclomine- and simethicone-containing product


name: Dicyclomine and simethicone only product


name: Dicyclomine and simethicone only product in oral dose form


name: Metoprolol- and telmisartan-containing product


name: Metoprolol and telmisartan only product in oral dose form


name: Percentage of typical eating occasion spent consuming food


name: Intermittent mandatory ventilation with synchronized-termination pressure control and assured constant airway pressure adjunct during the inflation phase


name: Laparoscopy and biopsy of lesion of liver


name: Mediastinoscopy and thoracoscopy with ventilation of lung


name: Ultrasonography guided biopsy of upper abdomen


name: Ultrasonography guided biopsy of pancreas


name: Laparoscopic ultrasonography guided biopsy of lesion of pancreas


name: Endoscopic ultrasonography guided biopsy of esophagus


name: Endoscopic ultrasonography guided biopsy of lesion of liver


name: Laparoscopic ultrasonography guided biopsy of lesion of liver


name: Endoscopic ultrasonography guided biopsy of lesion of pancreas


name: Reconstruction using nasolabial skin flap


name: Endoscopic ultrasonography guided biopsy of bronchus


name: Insertion of arterial catheter into peripheral artery


name: Itopride- and pantoprazole-containing product


name: Itopride and pantoprazole only product in oral dose form


name: Facilitation of ability to communicate about dying process


name: Dexrazoxane only product in parenteral dose form


name: Endoscopic ultrasonography guided biopsy of lung


name: Levosulpiride- and rabeprazole-containing product


name: Levosulpiride and rabeprazole only product


name: Levosulpiride and rabeprazole only product in oral dose form


name: Acetaminophen- and cetirizine- and phenylephrine-containing product


name: Acetaminophen and cetirizine and phenylephrine only product


name: Acetaminophen and cetirizine and phenylephrine only product in oral dose form


name: Injection of antineoplastic agent into neoplasm of brain tissue


name: Injection of drug or medicament into brain tissue


name: Injection of drug or medicament into cerebrospinal fluid


name: Injection of drug or medicament into skin


name: Injection of drug or medicament into pericardium


name: Injection of drug or medicament into testis


name: Injection of drug or medicament into tendon


name: Injection of drug or medicament into tendon of hand


name: Injection of drug or medicament into temporomandibular joint


name: Injection of drug or medicament into joint


name: Application of negative pressure wound dressing


name: Removal of negative pressure wound dressing


name: Replacement of negative pressure wound dressing


name: Metformin- and voglibose-containing product


name: Metformin and voglibose only product in oral dose form


name: Endoscopic ultrasonography guided biopsy of mediastinum


name: Ultrasonography guided biopsy of pericardium


name: Total replacement of knee joint using cone


name: Revision of total replacement of knee joint using cone


name: Endoscopic ultrasonography of peritoneum


name: Endoscopic ultrasonography of peritoneum and biopsy of intraabdominal organ


name: Sexual behavior with high risk of exposure to communicable disease


name: Ultrasonography guided biopsy of scrotum


name: Ultrasonography guided biopsy of prostate


name: Endoscopic ultrasonography guided biopsy of stomach


name: Endoscopic ultrasonography guided biopsy of retroperitoneum


name: Endoscopic ultrasonography guided biopsy of rectum


name: Ultrasonography guided aspiration of scrotum


name: Ultrasonography guided drainage of scrotum


name: Endoscopy of trachea using rigid bronchoscope


name: Endoscopy and biopsy of trachea using rigid bronchoscope


name: Laryngoscopy and biopsy of lesion of larynx


name: Endoscopic ultrasonography of peritoneum and biopsy of lesion of peritoneum


name: Endoscopy of trachea and biopsy of lesion of trachea using fiberoptic bronchoscope


name: Endoscopy of ventricle of brain and biopsy of lesion of ventricle of brain


name: Rigid bronchoscopy and biopsy of lesion of lung


name: Revision of total replacement of knee joint using stem


name: Total replacement of knee joint using knee stem


name: Endoscopic retrograde pancreatography guided biopsy of lesion of pancreas with contrast


name: Fiberoptic endoscopy of pharynx and/or larynx


name: Endoscopic retrograde cholangiography guided biopsy of lesion of bile duct with contrast


name: Endoscopic retrograde cholangiopancreatography guided biopsy of lesion of ampulla of Vater with contrast


name: Replacement of intrathecal implantable infusion pump


name: Robot assisted transoral partial excision of tongue


name: Custom-made silicone block reconstructive implant


name: Drug coated abdominal aorta endovascular stent-graft


name: Functional endoscopic sinus surgery - antrostomy via canine fossa


name: Implantation of dental zygomatic implant into zygomatic bone


name: Protein and/or protein derivative requirement


name: Total replacement of knee joint with bone allograft


name: Total replacement of knee joint with bone autograft


name: Total replacement of knee joint using modular metal augmentation


name: Total replacement of knee joint using rotating hinge prosthesis


name: Total knee replacement using valgus-varus constrained prosthesis


name: Percutaneous transluminal insertion of bare metal stent into coronary artery using fluoroscopic guidance with contrast


name: Implantable magnetic lesion localization marker


name: Laparoscopic intraoperative cholangiography with contrast


name: Laparoscopic percutaneous transhepatic cholangiography with contrast


name: Percutaneous transhepatic cholangiography guided laparoscopic biopsy of bile duct with contrast


name: Intraoperative cholangiography guided laparoscopic biopsy of bile duct with contrast


name: Continuous mandatory ventilation with sigh


name: Revision of total replacement of hip joint using mesh


name: Penetrating keratoplasty with implantation of posterior chamber intraocular lens


name: Bronchoscopy with biopsy of bronchus using electromagnetic navigation guidance


name: Replacement of intrathecal implantable infusion pump and pump segment of intrathecal catheter


name: Endoscopic retrograde cholangiopancreatography guided biopsy of sphincter of Oddi with contrast


name: Fluoroscopic angiography guided biopsy of heart with contrast


name: Percutaneous transluminal insertion of drug eluting stent into left main coronary artery using fluoroscopic guidance with contrast


name: Percutaneous transluminal balloon angioplasty of left main coronary artery


name: Method for estimating energy requirement


name: Method for estimating fat and oil requirement


name: Method for estimating protein and/or protein derivative requirement


name: Method for estimating vitamin requirement


name: Method for estimating mineral requirement


name: Method for estimating carbohydrate requirement


name: Method for estimating plant fiber requirement


name: Revision of total replacement of hip joint using cup-cage


name: Injection of human anti-D immunoglobulin


name: Intramuscular injection of human anti-D immunoglobulin


name: Intravenous infusion of human anti-D immunoglobulin


name: Offering of donor solid organ for transplant to subject


name: Intermittent mandatory ventilation with synchronized-termination pressure-control and assured constant airway pressure adjunct


name: Reconstruction of thumb using free skin flap


name: Pollicization of thumb using free skin flap


name: Cleaning of external fixation site with change of dressing


name: Revision of total replacement of hip joint using metal augmentation


name: Total replacement of hip joint using metal augmentation


name: Revision of total replacement of hip joint using liner exchange


name: Cleaning of tube insertion site with maintenance of tube and change of dressing


name: Preparation of injection for self administration by subject


name: Positioning subject for food and drink intake


name: Revision of total replacement of hip joint using cage


name: Positioning subject seated upright with spine straight


name: Bacitracin- and neomycin- and sulfacetamide-containing product


name: Bacitracin and neomycin and sulfacetamide only product


name: Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form


name: Etofylline and theophylline only product


name: Etofylline and theophylline only product in parenteral dose form


name: Performing dressing activity for full body of subject


name: Provision of snack between regular meals


name: Performing dressing activity for partial body of subject


name: Diet modified for low protein medical food


name: Education about nutrition influence on health


name: Alprostadil only product in cutaneous dose form


name: Ivermectin only product in cutaneous dose form


name: Parecoxib only product in parenteral dose form


name: Prolonged-release dispersion for injection


name: Assisting toileting activities using a commode chair


name: Preparation of physical therapy equipment


name: Tablet for oromucosal solution for gargle


name: Powder for oromucosal solution for gargle


name: Powder for oromucosal solution for mouthwash


name: Revision of total replacement of hip joint with allograft of bone


name: Performing search for missing subject of care


name: Connection of irrigation solution container to irrigation tube


name: Informing of subject's social support network


name: Assisting with collection of blood specimen for laboratory


name: Sclerotherapy dual injection and aspiration catheter


name: Replacement of dressing of insertion site of vascular catheter


name: Replacement of dressing of insertion site of cannula


name: Metal dental and/or maxillofacial surgical mesh


name: Metal and polymer dental and/or maxillofacial surgical mesh


name: Excision of ganglion cyst of popliteal fossa region of knee


name: Stimulation of breathing by rubbing back


name: Powder for solution for endotracheopulmonary instillation


name: Powder for suspension for endotracheopulmonary instillation


name: Collection of blood from umbilical cord immediately after delivery


name: Assessment using WHO performance status scale


name: Etofylline and theophylline only product in oral dose form


name: Correction of congenital anomaly of hand


name: Referral to basic skills training program


name: Auditory brainstem electric response audiometry with click stimulation


name: Auditory brainstem electric response audiometry with tone stimulation


name: Correction of congenital deformity of shoulder


name: Correction of congenital deformity of upper arm


name: Endoscopic excision of isthmus of thyroid gland


name: Robotic assisted closure of atrial septal defect


name: Surgical procedure on bilateral eye regions


name: Wide local excision of lesion of breast using magnetic seed marker


name: Correction of congenital anomaly of upper limb


name: Correction of congenital anomaly of lower limb


name: Sialendoscopic dilation of stenosis of salivary duct


name: Sialendoscopic removal of calculus from salivary gland


name: Endoscopic ultrasonography guided cystogastrostomy of pancreas


name: Alprazolam- and propranolol-containing product


name: Alprazolam and propranolol only product in oral dose form


name: Amisulpride only product in oromucosal dose form


name: Gabapentin- and nortriptyline-containing product


name: Gabapentin and nortriptyline only product


name: Gabapentin and nortriptyline only product in oral dose form


name: Gabapentin- and mecobalamin-containing product


name: Gabapentin and mecobalamin only product in oral dose form


name: Castor oil- and colophony-containing product


name: Levocetirizine- and montelukast-containing product


name: Levocetirizine and montelukast only product


name: Levocetirizine and montelukast only product in oral dose form


name: Moving subject to sitting on edge of bed from lying down


name: Sialendoscopic removal of mucus plug of salivary duct


name: Super resolution ultrasound imaging - action


name: Support for use of complementary therapy


name: Assessment of knowledge of complementary therapy


name: Assessment of use of complementary therapy


name: Arthroplasty of joint using robotic assistance


name: Arthroplasty of knee joint using robotic assistance


name: Arthroplasty of hip joint using robotic assistance


name: Unicompartmental knee arthroplasty using robotic assistance


name: Atenolol- and levamlodipine-containing product


name: Atenolol and levamlodipine only product in oral dose form


name: Revision of total replacement of hip joint with bone autograft


name: Revision of total replacement of hip joint using impaction bone graft


name: Total replacement of hip joint using impaction bone graft


name: Total replacement of hip joint using mesh


name: Total replacement of hip joint using ring


name: Total replacement of hip joint using bone allograft


name: Total replacement of hip joint using autogenous bone graft


name: Total replacement of hip joint using cage


name: Aortic root enlargement using anterior approach


name: Aortic root enlargement using posterior approach


name: Endoscopic modified Lothrop procedure on frontal sinus


name: Reconstruction of nasopharynx using pedicle nasoseptal flap


name: Resection of non-ruptured aneurysm of carotid artery with interposition graft replacement


name: Calgary Depression Scale for Schizophrenia


name: Piers-Harris Children's Self-Concept Scale


name: Percutaneous division of tendon using needle


name: Standardised Assessment of Personality - Abbreviated Scale


name: Thyrotropin alfa only product in parenteral dose form


name: Solution for hemodiafiltration or hemodialysis


name: Excision arthroplasty of hip joint with insertion of cement spacer


name: Implantation of artificial meniscus into knee joint


name: Personality Diagnostic Questionnaire Version 4


name: Conners Comprehensive Behavior Rating Scales


name: Social Anxiety Scale for Children-Revised


name: Reconstruction of lip using free myocutaneous flap with microvascular anastomosis


name: Amlodipine- and metoprolol-containing product


name: Amlodipine and metoprolol only product in oral dose form


name: Oromucosal solution for gargle or mouthwash


name: Insertion of pillar shaped implant into soft palate


name: Prolonged-release vaginal delivery system


name: Prolonged-release transdermal delivery system


name: Conventional release solution for cardioplegia


name: Posterolateral rotatory drawer test of elbow


name: Intradermal radiofrequency ablation system


name: Intradermal allergy testing adhesive strip


name: Transapical transcatheter implantation of bioprosthetic mitral valve prosthesis into mitral annuloplasty ring using fluoroscopic and transesophageal echocardiographic guidance


name: Acetaminophen- and chlorzoxazone- and diclofenac-containing product


name: Acetaminophen and chlorzoxazone and diclofenac only product


name: Acetaminophen and chlorzoxazone and diclofenac only product in oral dose form


name: Duloxetine- and mecobalamin-containing product


name: Duloxetine and mecobalamin only product in oral dose form


name: Acetaminophen- and diclofenac- and serrapeptase-containing product


name: Acetaminophen and diclofenac and serrapeptase only product


name: Acetaminophen and diclofenac and serrapeptase only product in oral dose form


name: X-ray guided insertion of marker into breast


name: Ultrasonography guided insertion of magnetic marker into left breast


name: Ultrasonography guided insertion of magnetic marker into right breast


name: Ultrasonography guided insertion of magnetic marker into bilateral breasts


name: Stereotactic mammography guided insertion of magnetic marker into breast


name: Stereotactic mammography guided insertion of magnetic marker into left breast


name: Stereotactic mammography guided insertion of magnetic marker into right breast


name: Stereotactic mammography guided insertion of magnetic marker into bilateral breasts


name: Ultrasonography guided insertion of magnetic marker into breast


name: X-ray guided insertion of magnetic marker into bilateral breasts


name: X-ray guided insertion of magnetic marker into left breast


name: X-ray guided insertion of magnetic marker into right breast


name: X-ray guided insertion of magnetic marker into breast


name: Code on Dental Procedures and Nomenclature, 2023


name: intraoral tomosynthesis - comprehensive series of radiographic images


name: intraoral tomosynthesis - bitewing radiographic image


name: intraoral tomosynthesis - periapical radiographic image


name: intraoral tomosynthesis - comprehensive series of radiographic images - image capture only


name: intraoral tomosynthesis - bitewing radiographic image - image capture only


name: intraoral tomosynthesis - periapical radiographic image - image capture only


name: Pfizer-BioNTech Covid-19 vaccine administration - third dose


name: Pfizer-BioNTech Covid-19 vaccine administration - booster dose


name: Moderna Covid-19 vaccine administration - third dose


name: Moderna Covid-19 vaccine administration - booster dose


name: Janssen Covid-19 vaccine administration - booster dose


name: Pfizer-BioNTech Covid-19 vaccine administration tris-sucrose pediatric - first dose


name: Pfizer-BioNTech Covid-19 vaccine administration tris-sucrose pediatric - second dose


name: vaccine administration - human papillomavirus - Dose 1


name: vaccine administration - human papillomavirus - Dose 2


name: vaccine administration - human papillomavirus - Dose 3


name: removal of implant body not requiring bone removal or flap elevation


name: guided tissue regeneration - resorbable barrier, per implant


name: guided tissue regeneration - non-resorbable barrier, per implant


name: replacement of restorative material used to close an access opening of a screw-retained implant supported prosthesis, per implant


name: guided tissue regeneration, edentulous area - resorbable barrier, per site


name: guided tissue regeneration, edentulous area - non-resorbable barrier, per site


name: reline custom sleep apnea appliance (indirect)


name: Upper gastrointestinal capsule endoscopy study


name: Five Facet Mindfulness Questionnaire panel


name: IDH1 gene exon 4 targeted mutation analysis


name: IDH2 gene exon 4 targeted mutation analysis


name: Clotting time.extrinsic coagulation system activated.platelets inhibited


name: Clot formation.extrinsic coagulation system activated.platelets inhibited


name: Norwalk Community Health Center Screening Tool


name: Lipopolysaccharide-responsive beige-like anchor protein deficiency panel


name: Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity


name: Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity


name: Social Determinants of Health screening report


name: Cholesterol.in lipoprotein (little a) & Cholesterol.in LDL panel


name: Mannose-6-phosphate isomerase & phosphomannomutase 1 panel


name: Protein fractions.oligoclonal bands panel


name: Homocysteine & Methylmalonate & 2-Methylcitrate panel


name: Center for Epidemiologic Studies Depression Scale panel


name: Cells.CD4.Tumor necrosis factor alfa-expressing/Cells.CD4


name: Bovine Tuberculosis Comparative Cervical Test panel


name: Albumin:MCnc:XXX:Urine:Qn:Detection limit <= 20 mg/L


name: Medial &or lateral instability^W full extension:Find:Pt:Knee:Ord:Measured


name: Anterior-posterior instability^W 90 degree flexion:Find:Pt:Knee:Ord:Measured


name: Prostate cancer multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: IDH1 gene exon 4 targeted mutation analysis:PrThr:Pt:Bld/Bone mar:Ord:Molgen


name: IDH2 gene exon 4 targeted mutation analysis:PrThr:Pt:Bld/Bone mar:Ord:Molgen


name: Rubella virus Ab.IgG index:ACnc:Pt:Ser+CSF:Qn


name: Influenza virus B RNA:PrThr:Pt:Saliva:Ord:Probe.amp.tar


name: Influenza virus A RNA:PrThr:Pt:Saliva:Ord:Probe.amp.tar


name: Influenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel:-:Pt:XXX:-:Probe.amp.tar


name: Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis DNA:Prid:Pt:XXX:Nom:Probe.amp.tar


name: Gliadin 33 mer peptide:MCnc:Pt:Stool:Qn:IA


name: Amino Acids Urea Cycle Panel:-:Pt:Ser/Plas:-:LC/MS/MS


name: Mentha balsamea Wild Ab.IgG:ACnc:Pt:Ser:Qn


name: Helianthus annuus seed Ab.IgG:ACnc:Pt:Ser:Qn


name: Allergen Mushroom mix 2 (Xerocomus, Boletus) Ab.IgG:ACnc:Pt:Ser:Qn


name: Capra aegagrus hircus Ab.IgG:ACnc:Pt:Ser:Qn


name: Foeniculum vulgare fresh Ab.IgG:ACnc:Pt:Ser:Qn


name: Brassica oleracea var borecole Ab.IgG:ACnc:Pt:Ser:Qn


name: Brassica oleracea var. Sabauda Ab.IgG:ACnc:Pt:Ser:Qn


name: Pisum sativum var. saccharatum Ab.IgG:ACnc:Pt:Ser:Qn


name: (Agaricus bisporus+Pleurotus ostreatus+Lentinula edodes+Cantharellus) Ab.IgG:ACnc:Pt:Ser:Qn


name: Carnitine Free & Total & Acylcarnitine Panel:-:Pt:Urine:-


name: Lipopolysaccharide-responsive beige-like anchor protein deficiency panel:-:Pt:Bld:-


name: Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity:Arb:Pt:Bld:Qn:Flow cytometry


name: Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity:Arb:Pt:Bld:Qn:Flow cytometry


name: Glial fibrillary acidic protein:MCnc:Pt:Ser:Qn:IA


name: Epstein Barr virus DNA:LnCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Epstein Barr virus DNA:LnCnc:Pt:Bld:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:LnCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:LnCnc:Pt:Bld:Qn:Probe.amp.tar


name: Herpes virus 7 DNA:LnCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Herpes virus 7 DNA:LnCnc:Pt:Bld:Qn:Probe.amp.tar


name: Herpes virus 8 DNA:LnCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Herpes virus 8 DNA:LnCnc:Pt:Bld:Qn:Probe.amp.tar


name: Varicella zoster virus DNA:LnCnc:Pt:Bld:Qn:Probe.amp.tar


name: Pneumocystis jiroveci DNA:LnCnc:Pt:Respiratory System Specimen:Qn:Probe.amp.tar


name: SMN1 gene silent carrier analysis:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: Genetic disease analysis overall carrier interpretation:Imp:Pt:Bld/Tiss:Nar:Molgen


name: CTNS related multigene analysis:Prid:Pt:Body fld+Ser/Plas:Nom:Molgen


name: Polymorphonuclear cells:NCnc:Pt:Dial fld prt:Qn:Automated count


name: Plasma cells/100 leukocytes:NFr:Pt:Synv fld:Qn


name: Chlamydia trachomatis & Neisseria gonorrhoeae rRNA panel:-:Pt:Thrt:-:Probe.amp.tar


name: Cholesterol.in lipoprotein (little a) & Cholesterol.in LDL panel:-:Pt:Ser:-


name: Cholesterol.in LDL^corrected for Cholesterol.in lipoprotein (little a):MCnc:Pt:Ser:Qn:Calculated


name: traMADol & metabolites panel:-:Pt:Urine:-:Confirm


name: Mannose-6-phosphate isomerase & phosphomannomutase 1 panel:-:Pt:WBC:-


name: Acylcarnitine Analysis Post Mortem:Find:Pt:XXX:Doc


name: Legionella pneumophila serogroup 1:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Legionella pneumophila non serogroup 1:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Platelet disorders multigene analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: Protein fractions.oligoclonal bands:Num:Pt:Ser/Plas:Qn:Isoelectric focusing


name: Protein fractions.oligoclonal bands:Imp:Pt:CSF:Nom:Isoelectric focusing


name: Protein fractions.oligoclonal bands panel:-:Pt:Ser+CSF:-:Isoelectric focusing


name: PALB2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Mycobacterium sp comparative reaction interpretation:Imp:Pt:Skin:Nar


name: Mycobacterium bovis reaction wheal^3D post dose mammalian tuberculin ID:Diam:Pt:Skin:Ord


name: Homocysteine & Methylmalonate & 2-Methylcitrate panel:-:Pt:Bld.dot:-


name: S100 calcium binding protein B:MCnc:Pt:Body fld:Qn


name: Testosterone.free^1st specimen post XXX challenge:MCnc:Pt:Ser:Qn


name: Testosterone.free^2nd specimen post XXX challenge:MCnc:Pt:Ser:Qn


name: 21-Deoxycortisol^1st specimen post XXX challenge:MCnc:Pt:Ser:Qn


name: 21-Deoxycortisol^2nd specimen post XXX challenge:MCnc:Pt:Ser:Qn


name: 21-Deoxycortisol^3rd specimen post XXX challenge:MCnc:Pt:Ser:Qn


name: 21-Deoxycortisol^4th specimen post XXX challenge:MCnc:Pt:Ser:Qn


name: 21-Deoxycortisol^5th specimen post XXX challenge:MCnc:Pt:Ser:Qn


name: Vasopressin^1st specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Vasopressin^2nd specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Vasopressin^3rd specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Vasopressin^4th specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Vasopressin^5th specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Vasopressin^6th specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Vasopressin^7th specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Vasopressin^8th specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Vasopressin^9th specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Vasopressin^10th specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Vasopressin^11th specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Vasopressin^12th specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Glucagon^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Renin^1st specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Renin^2nd specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Renin^3rd specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Renin^4th specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Alpha subunit.free^1st specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Alpha subunit.free^2nd specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Alpha subunit.free^3rd specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Alpha subunit.free^4th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Alpha subunit.free^5th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Alpha subunit.free^6th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Alpha subunit.free^7th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor-I^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Testosterone^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Vitamin A/Retinol binding protein:Ratio:Pt:Ser/Plas:Qn


name: Zinc finger protein of the cerebellum 4 Ab:PrThr:Pt:CSF:Ord:Line blot


name: Dengue virus 1+2+3+4 non-structural protein 1 (nsP1) Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IA


name: Cell count & Differential panel:-:Pt:Amnio fld:-:Manual count


name: Other cells:NCnc:Pt:Amnio fld:Qn:Manual count


name: Cells.CD4+CD154+/Cells.CD4^after stimulation with SARS-CoV-2 Spike peptide:NFr:Pt:Bld:Qn


name: Cells.CD4.Interferon gamma-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Spike peptide:NFr:Pt:Bld:Qn


name: Cells.CD4.Tumor necrosis factor alfa-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Spike peptide:NFr:Pt:Bld:Qn


name: Cells.CD4+CD154+/Cells.CD4^after stimulation with SARS-CoV-2 Nucleocapsid peptide:NFr:Pt:Bld:Qn


name: Cells.CD4.Interferon gamma-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Nucleocapsid peptide:NFr:Pt:Bld:Qn


name: Cells.CD4.Tumor necrosis factor alfa-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Nucleocapsid peptide:NFr:Pt:Bld:Qn


name: Giardia lamblia bg gene:Geno:Pt:XXX:Nom:Molgen


name: Cryptosporidium sp 18S-LC2 rRNA:Geno:Pt:XXX:Nom:Molgen


name: Giardia lamblia gdh gene:Geno:Pt:XXX:Nom:Molgen


name: Bacteria producing polysaccharide from sucrose:PrThr:Pt:Isolate:Ord


name: Giardia lamblia tpi gene:Geno:Pt:XXX:Nom:Molgen


name: Monkeypox virus clade II DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Monkeypox virus clade I DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Rickettsia conorii Ab.IgG & IgM:Imp:Pt:Ser:Nom


name: Staphylococcus aureus:PrThr:Pt:XXX:Ord:Organism specific culture


name: Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype:Prid:Pt:XXX:Nom:Organism specific culture


name: Enterobacteriaceae.carbapenem resistance panel:-:Pt:Anal:-:Organism specific culture


name: Enterobacteriaceae.carbapenemase resistance phenotype:Prid:Pt:Anal:Nom:Organism specific culture


name: Enterobacteriaceae.carbapenemase resistance phenotype.OXA-48:Prid:Pt:Anal:Nom:Organism specific culture


name: Yeast & Candida sp identification panel:-:Pt:XXX:-:Organism specific culture


name: Urinary tract pathogens panel:-:Pt:Urine:-:Culture


name: Gram positive bacteria identified:Prid:Pt:Isolate:Nom:Organism specific culture


name: Enterococcus species.vancomycin resistant:Prid:Pt:XXX:Nom:Organism specific culture


name: Pseudomonas aeruginosa:PrThr:Pt:Respiratory.lower:Ord:Organism specific culture


name: Cronobacter sakazakii:PrThr:Pt:Envir:Ord:Organism specific culture


name: Gram negative bacteria.colistin resistant identified:Prid:Pt:Stool:Nom:Organism specific culture


name: Staph aureus and MRSA screening panel:-:Pt:XXX:-:Organism specific culture


name: Dengue virus Ab.IgG Panel:-:Pt:Ser/Plas/Bld:-


name: Dengue virus 1+2+3+4 non-structural protein 1 (nsP1) Ab.IgG:ACnc:Pt:Ser/Plas:Qn:IA


name: Bovine Tuberculosis Comparative Cervical Test panel:-:Pt:Skin:-


name: Volatile Organic Compounds associated with SARS-CoV-2 infection:PrThr:Pt:Exhl gas:Ord:GC-MS


name: Varicella zoster virus DNA:LnCnc:Pt:CSF:Qn:Probe.amp.tar


name: Glucagon^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Vasopressin^13th specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Provide feeding through new or existing surgically-placed tubes


name: Racquet Sports (Tennis, Racquetball, etc.)


name: Stretching Exercises (stretching out your muscles)


name: Knee Society Score pre-op panel:-:Pt:^Patient:-:Knee Society Score


name: Pre-op total score:Score:Pt:^Patient:Qn:Knee Society Score


name: Pre-op objective knee indicators score:Score:Pt:^Patient:Qn:Knee Society Score


name: Pre-op symptoms score:Score:Pt:^Patient:Qn:Knee Society Score


name: Pre-op patient expectations score:Score:Pt:^Patient:Qn:Knee Society Score


name: Pre-op functional activities score:Score:Pt:^Patient:Qn:Knee Society Score


name: Pre-op discretionary knee activities score:Score:Pt:^Patient:Qn:Knee Society Score


name: Knee Society Score post-op panel:-:Pt:^Patient:-:Knee Society Score


name: Post-op total score:Score:Pt:^Patient:Qn:Knee Society Score


name: Post-op objective knee indicators score:Score:Pt:^Patient:Qn:Knee Society Score


name: Post-op symptoms score:Score:Pt:^Patient:Qn:Knee Society Score


name: Post-op patient expectations score:Score:Pt:^Patient:Qn:Knee Society Score


name: Post-op functional activities score:Score:Pt:^Patient:Qn:Knee Society Score


name: Post-op discretionary knee activities score:Score:Pt:^Patient:Qn:Knee Society Score


name: Dental model prior authorization:Find:Pt:^Patient:Doc


name: Episode of care medical records:Find:Pt:^Patient:Doc:Transplant surgery


name: Synoptic report:Find:Pt:Skin melanoma:Nar:Surgical oncology


name: Segmental wall motion panel:-:Pt:Heart.ventricle.left:-:US


name: Small bowel capsule endoscopy study:Find:Pt:^Patient:Doc


name: Colon capsule endoscopy study:Find:Pt:^Patient:Doc


name: Upper gastrointestinal capsule endoscopy study:Find:Pt:^Patient:Doc


name: Bronchial endoscopic ultrasound study:Find:Pt:^Patient:Doc


name: Acting with awareness score:Score:Pt:^Patient:Qn:FFMQ


name: Five Facet Mindfulness Questionnaire panel:-:Pt:^Patient:-:FFMQ


name: Harris Hip Score panel:-:Pt:^Patient:-:Harris Hip Score


name: Absence of deformity score:Score:Pt:^Patient:Qn:Harris Hip Score


name: Range of motion score:Score:Pt:^Patient:Qn:Harris Hip Score


name: Total Score:Score:Pt:^Patient:Qn:Harris Hip Score


name: Pre-op patient satisfaction score:Score:-:^Patient:Qn:Knee Society Score


name: Abduction range of motion:Find:Pt:Hip:Ord


name: Adduction range of motion:Find:Pt:Hip:Ord


name: External rotation range of motion:Find:Pt:Hip:Ord


name: Internal rotation range of motion:Find:Pt:Hip:Ord


name: Post-op patient satisfaction score:Score:Pt:^Patient:Qn:Knee Society Score


name: Time period start & end panel:-:Pt:XXX:-


name: Multisection^W vasodilator IV:Find:Pt:Pelvis>Penis vessels:Doc:US.doppler


name: Norwalk Community Health Center Screening Tool:-:Pt:^Patient:-:NCHC


name: Brief Resilience Scale panel:-:Pt:^Patient:-:BRS


name: Views^W Tl-201 IV:Find:Pt:Neck>Thyroid gland:Doc:NM


name: REMS addressed risk:-:-:^FDA package insert:Nar


name: Progress note:Find:Pt:Outpatient:Doc:Bone marrow transplant


name: Progress note:Find:Pt:Outpatient:Doc:Cardiovascular disease+Pulmonary disease


name: Progress note:Find:Pt:Outpatient:Doc:Child and adolescent psychiatry


name: Progress note:Find:Pt:Outpatient:Doc:Clinical cardiac electrophysiology


name: Progress note:Find:Pt:Outpatient:Doc:Colon and rectal surgery


name: Progress note:Find:Pt:Outpatient:Doc:Heart failure+Transplant cardiology


name: Mechanical circulatory support+progress note:Find:Pt:Outpatient:Doc:{Role}


name: Progress note:Find:Pt:Outpatient:Doc:Medical aid in dying


name: Progress note:Find:Pt:Outpatient:Doc:Neonatal perinatal medicine


name: Progress note:Find:Pt:Outpatient:Doc:Neurology w special qualifications in child neuro


name: Progress note:Find:Pt:Outpatient:Doc:Nutrition and dietetics


name: Progress note:Find:Pt:Outpatient:Doc:Obstetrics and Gynecology


name: Progress note:Find:Pt:Outpatient:Doc:Oral and maxillofacial surgery


name: Progress note:Find:Pt:Outpatient:Doc:Pediatric infectious diseases


name: Progress note:Find:Pt:Outpatient:Doc:Pediatric transplant hepatology


name: Progress note:Find:Pt:Outpatient:Doc:Physical medicine and rehab


name: Progress note:Find:Pt:Outpatient:Doc:Reproductive endocrinology and infertility


name: Progress note:Find:Pt:Outpatient:Doc:Solid organ transplant


name: Progress note:Find:Pt:Outpatient:Doc:Surgery of the hand


name: Progress note:Find:Pt:Outpatient:Doc:Wound care management


name: Progress note:Find:Pt:Outpatient:Doc:Wound, ostomy, and continence care


name: Progress note:Find:Pt:Hospital:Doc:Blood banking and transfusion medicine


name: Progress note:Find:Pt:Hospital:Doc:Bone marrow transplant


name: Progress note:Find:Pt:Hospital:Doc:Cardiovascular disease+Pulmonary disease


name: Progress note:Find:Pt:Hospital:Doc:Child and adolescent psychiatry


name: Progress note:Find:Pt:Hospital:Doc:Clinical cardiac electrophysiology


name: Progress note:Find:Pt:Hospital:Doc:Colon and rectal surgery


name: Progress note:Find:Pt:Hospital:Doc:Heart failure+Transplant cardiology


name: Mechanical circulatory support+progress note:Find:Pt:Hospital:Doc:{Role}


name: Progress note:Find:Pt:Hospital:Doc:Medical aid in dying


name: Progress note:Find:Pt:Hospital:Doc:Neonatal perinatal medicine


name: Progress note:Find:Pt:Hospital:Doc:Neurology w special qualifications in child neuro


name: Progress note:Find:Pt:Hospital:Doc:Nutrition and dietetics


name: Progress note:Find:Pt:Hospital:Doc:Obstetrics and Gynecology


name: Progress note:Find:Pt:Hospital:Doc:Oral and maxillofacial surgery


name: Progress note:Find:Pt:Hospital:Doc:Pediatric infectious diseases


name: Progress note:Find:Pt:Hospital:Doc:Pediatric transplant hepatology


name: Progress note:Find:Pt:Hospital:Doc:Physical medicine and rehab


name: Progress note:Find:Pt:Hospital:Doc:Rapid response team


name: Progress note:Find:Pt:Hospital:Doc:Reproductive endocrinology and infertility


name: Progress note:Find:Pt:Hospital:Doc:Solid organ transplant


name: Progress note:Find:Pt:Hospital:Doc:Surgery of the hand


name: Progress note:Find:Pt:Hospital:Doc:Wound care management


name: Progress note:Find:Pt:Hospital:Doc:Wound, ostomy, and continence care


name: Progress note:Find:Pt:Outpatient:Doc:Maternal and fetal medicine


name: Progress note:Find:Pt:Telephone encounter+Hospital:Doc:Maternal and fetal medicine


name: Progress note:Find:Pt:Hospital:Doc:Maternal and fetal medicine


name: Progress note:Find:Pt:Telephone encounter+Outpatient:Doc:Maternal and fetal medicine


name: Social Determinants of Health screening report:Find:Pt:^Patient:Doc


name: Discharge summary note:Find:Pt:{Setting}:Doc:Undersea and hyperbaric medicine


name: Discharge summary note:Find:Pt:{Setting}:Doc:Surgical oncology


name: Discharge summary note:Find:Pt:{Setting}:Doc:Reproductive endocrinology and infertility


name: Discharge summary note:Find:Pt:{Setting}:Doc:Community health care


name: Discharge summary note:Find:Pt:{Setting}:Doc:Integrative medicine


name: Discharge summary note:Find:Pt:{Setting}:Doc:Sports medicine


name: Discharge summary note:Find:Pt:{Setting}:Doc:Chiropractic medicine


name: Discharge summary note:Find:Pt:{Setting}:Doc:Cardiac surgery


name: Discharge summary note:Find:Pt:{Setting}:Doc:Transplant surgery


name: Discharge summary note:Find:Pt:Urgent care center:Doc:{Role}


name: Estimated lung age:Time:Pt:^Patient:Qn:Based on clinical data


name: Center for Epidemiologic Studies Depression Scale panel:-:RptPeriod:^Patient:-:CES-D


name: Views for metastasis^W Sr-89 IV:Find:Pt:XXX>Bones:Doc:NM


name: Endoscopic ultrasound study:Find:Pt:Upper GI tract:Doc:US


name: Multisection^W contrast percutaneous intraperitoneal:Find:Pt:Abdomen>Peritoneum:Doc:MR


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen>Kidney.left:Doc:MR


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen>Kidney.right:Doc:MR


name: Loneliness Office of National Statistics score:Score:Pt:^Patient:Qn:R-Outcomes


name: Progress note:Find:Pt:Outpatient:Doc:Blood banking and transfusion medicine


name: Corticotropin^9th specimen post XXX challenge|Pt|Plas


name: Vasopressin^1st specimen post XXX challenge|Pt|Plas


name: Vasopressin^2nd specimen post XXX challenge|Pt|Plas


name: MR|Kidney|Guidance for percutaneous biopsy|Laterality:ANY


name: Mechanical circulatory support+progress note|ANYRole|ANYSetting


name: after stimulation with SARS-CoV-2 Spike peptide


name: after stimulation with SARS-CoV-2 Nucleocapsid peptide


name: corrected for Cholesterol.in lipoprotein (little a)


name: Medial &or lateral instability^W full extension


name: Anterior-posterior instability^W 90 degree flexion


name: Cells.CD4+CD154+ /Cells.CD4^after stimulation with SARS-CoV-2 Spike peptide


name: Cells.CD4.Interferon gamma-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Spike peptide


name: Cells.CD4.Tumor necrosis factor alfa-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Spike peptide


name: Cells.CD4.Tumor necrosis factor alfa-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Nucleocapsid peptide


name: 21-Deoxycortisol^1st specimen post XXX challenge


name: 21-Deoxycortisol^2nd specimen post XXX challenge


name: 21-Deoxycortisol^3rd specimen post XXX challenge


name: 21-Deoxycortisol^4th specimen post XXX challenge


name: 21-Deoxycortisol^5th specimen post XXX challenge


name: Alpha subunit.free^1st specimen post XXX challenge


name: Alpha subunit.free^2nd specimen post XXX challenge


name: Alpha subunit.free^3rd specimen post XXX challenge


name: Alpha subunit.free^4th specimen post XXX challenge


name: Alpha subunit.free^5th specimen post XXX challenge


name: Alpha subunit.free^6th specimen post XXX challenge


name: Alpha subunit.free^7th specimen post XXX challenge


name: Cells.CD4.Interferon gamma-expressing/Cells.CD4^after stimulation with SARS-CoV-2 Nucleocapsid peptide


name: Cells.CD4+CD154+/Cells.CD4^after stimulation with SARS-CoV-2 Nucleocapsid peptide


name: Cells.CD4+CD154+/Cells.CD4^after stimulation with SARS-CoV-2 Spike peptide


name: Cholesterol.in LDL^corrected for Cholesterol.in lipoprotein (little a)


name: Glucagon^6th specimen post XXX challenge


name: Glucagon^7th specimen post XXX challenge


name: Insulin-like growth factor-I^9th specimen post XXX challenge


name: Multisection^W contrast percutaneous intraperitoneal


name: Testosterone.free^1st specimen post XXX challenge


name: Testosterone.free^2nd specimen post XXX challenge


name: Testosterone^9th specimen post XXX challenge


name: Vasopressin^10th specimen post XXX challenge


name: Vasopressin^11th specimen post XXX challenge


name: Vasopressin^12th specimen post XXX challenge


name: Vasopressin^13th specimen post XXX challenge


name: Vasopressin^3rd specimen post XXX challenge


name: Vasopressin^4th specimen post XXX challenge


name: Vasopressin^5th specimen post XXX challenge


name: Vasopressin^6th specimen post XXX challenge


name: Vasopressin^7th specimen post XXX challenge


name: Vasopressin^8th specimen post XXX challenge


name: Vasopressin^9th specimen post XXX challenge


name: Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel | Throat | Microbiology Panels


name: Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype and Enterococcus species.vancomycin resistant panel | XXX | Microbiology Panels


name: Mycobacterium bovis reaction wheal | Skin | Skin challenge


name: Mycobacterium sp comparative reaction interpretation | Skin | Skin challenge


name: Insulin type | Serum or Plasma | Chemistry - non-challenge


name: Acylcarnitine Analysis Post Mortem | XXX | Chemistry - non-challenge


name: Carnitine free and total and acylcarnitine panel | Urine | Chemistry - non-challenge


name: Cell count and Differential panel | Amniotic fluid | Hematology and Cell Count Panels


name: Clotting time.extrinsic coagulation system activated.platelets inhibited | Blood | Coagulation


name: Clot formation.extrinsic coagulation system activated.platelets inhibited | Blood | Coagulation


name: B cell median channel shift | Patient and blood | Blood bank


name: B cell median channel shift | Patient and blood | Serum | Blood bank


name: B cell crossmatch | Patient and blood | Blood bank


name: B cell crossmatch | Patient and blood | Serum | Blood bank


name: T cell median channel shift | Patient and blood | Blood bank


name: T cell median channel shift | Patient and blood | Serum | Blood bank


name: T cell crossmatch | Patient and blood | Blood bank


name: T cell crossmatch | Patient and blood | Serum | Blood bank


name: Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity | Blood | Cell markers


name: Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity | Blood | Cell markers


name: Prostate cancer multigene analysis | Blood or Tissue | Molecular pathology


name: Platelet disorders multigene analysis | Blood or Tissue | Molecular pathology


name: Genetic disease analysis overall carrier interpretation | Blood or Tissue | Molecular pathology


name: CTNS related multigene analysis | Bodyfluid and Serum or Plasma | Mutations


name: NUDT15 gene c.50_55dup&c.415C>T | Blood | Mutations


name: NUDT15 gene c.415C>T | Blood | Mutations


name: NUDT15 gene c.50_55dup | Blood | Mutations


name: NUDT15 gene c.50_55del | Blood | Mutations


name: NUDT15 gene c.416G>A | Blood | Mutations


name: Referral lab test reference range | Referral lab test | Miscellaneous tests


name: Referral lab test name | Referral lab test | Miscellaneous tests


name: COVID-19 Intubation Progress note | Hospital | Document ontology


name: COVID-19 Intubation Progress note | Outpatient | Document ontology


name: COVID-19 Progress note | Hospital | Document ontology


name: COVID-19 Progress note | Outpatient | Document ontology


name: Progress note | Telehealth+Outpatient | Document ontology


name: Progress note | Telephone encounter+Hospital | Document ontology


name: Progress note | Telephone encounter+Outpatient | Document ontology


name: Discharge summary note | Urgent care center | Document ontology


name: Portable medical order administrative information | Patient | Clinical


name: SMN1 gene silent carrier analysis | Blood or Tissue | Molecular pathology


name: ogalvibart, crexavibart drug combination


name: spleen aminopeptide oral lyophilized powder


name: thyme extract and ivy extract drug combination


name: Reconstructive Surgical Procedures, Esthetic


name: Information Motivation Behavioral Skills Model


name: Vesicular Monoamine Transporter Type 2 Imaging


name: Asian American Native Hawaiian and Pacific Islander


name: Serial Sectioning Transmission Electron Microscopy


name: Serial Block-Face Scanning Electron Microscopy


name: Fenestrated Endovascular Aneurysm Repair


name: Complementary and Alternative Medicine Practitioners


name: Australian Aboriginal and Torres Strait Islander Peoples


name: Symbiont Induced Cytoplasmic Incompatibility


name: Nuclear-Cytoplasmic Incompatibility in Plants


name: Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; each additional 30 minutes by a physician or other qualified health care professional, per calendar month (List separately in addition to code for primary procedure)


name: Principal care management services, for a single high-risk disease, with the following required elements: one complex chronic condition expected to last at least 3 months, and that places the patient at significant risk of hospitalization, acute exacerbation/decompensation, functional decline, or death, the condition requires development, monitoring, or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen and/or the management of the condition is unusually complex due to comorbidities, ongoing communication and care coordination between relevant practitioners furnishing care; first 30 minutes provided personally by a physician or other qualified health care professional, per calendar month.


name: Principal care management services, for a single high-risk disease, with the following required elements: one complex chronic condition expected to last at least 3 months, and that places the patient at significant risk of hospitalization, acute exacerbation/decompensation, functional decline, or death, the condition requires development, monitoring, or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen and/or the management of the condition is unusually complex due to comorbidities, ongoing communication and care coordination between relevant practitioners furnishing care; each additional 30 minutes provided personally by a physician or other qualified health care professional, per calendar month (List separately in addition to code for primary procedure)


name: Principal care management services, for a single high-risk disease, with the following required elements: one complex chronic condition expected to last at least 3 months, and that places the patient at significant risk of hospitalization, acute exacerbation/decompensation, functional decline, or death, the condition requires development, monitoring, or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen and/or the management of the condition is unusually complex due to comorbidities, ongoing communication and care coordination between relevant practitioners furnishing care; first 30 minutes of clinical staff time directed by physician or other qualified health care professional, per calendar month.


name: Principal care management services, for a single high-risk disease, with the following required elements: one complex chronic condition expected to last at least 3 months, and that places the patient at significant risk of hospitalization, acute exacerbation/decompensation, functional decline, or death, the condition requires development, monitoring, or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen and/or the management of the condition is unusually complex due to comorbidities, ongoing communication and care coordination between relevant practitioners furnishing care; each additional 30 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (List separately in addition to code for primary procedure)


name: Anesthesia for percutaneous image-guided neuromodulation or intravertebral procedures (eg, kyphoplasty, vertebroplasty) on the spine or spinal cord; cervical or thoracic


name: Anesthesia for percutaneous image-guided neuromodulation or intravertebral procedures (eg, kyphoplasty, vertebroplasty) on the spine or spinal cord; lumbar or sacral


name: Exclusion of left atrial appendage, open, any method (eg, excision, isolation via stapling, oversewing, ligation, plication, clip)


name: Exclusion of left atrial appendage, open, performed at the time of other sternotomy or thoracotomy procedure(s), any method (eg, excision, isolation via stapling, oversewing, ligation, plication, clip) (List separately in addition to code for primary procedure)


name: Exclusion of left atrial appendage, thoracoscopic, any method (eg, excision, isolation via stapling, oversewing, ligation, plication, clip)


name: Transcatheter placement and subsequent removal of cerebral embolic protection device(s), including arterial access, catheterization, imaging, and radiological supervision and interpretation, percutaneous (List separately in addition to code for primary procedure)


name: Harvest of upper extremity artery, 1 segment, for coronary artery bypass procedure, endoscopic


name: Endovascular stent repair of coarctation of the ascending, transverse, or descending thoracic or abdominal aorta, involving stent placement; across major side branches


name: Endovascular stent repair of coarctation of the ascending, transverse, or descending thoracic or abdominal aorta, involving stent placement; not crossing major side branches


name: Percutaneous transluminal angioplasty of native or recurrent coarctation of the aorta


name: Drug-induced sleep endoscopy, with dynamic evaluation of velum, pharynx, tongue base, and larynx for evaluation of sleep-disordered breathing, flexible, diagnostic


name: Laser interstitial thermal therapy (LITT) of lesion, intracranial, including burr hole(s), with magnetic resonance imaging guidance, when performed; single trajectory for 1 simple lesion


name: Laser interstitial thermal therapy (LITT) of lesion, intracranial, including burr hole(s), with magnetic resonance imaging guidance, when performed; multiple trajectories for multiple or complex lesion(s)


name: Laminectomy, facetectomy, or foraminotomy (unilateral or bilateral with decompression of spinal cord, cauda equina and/or nerve root[s] [eg, spinal or lateral recess stenosis]), during posterior interbody arthrodesis, lumbar; single vertebral segment (List separately in addition to code for primary procedure)


name: Laminectomy, facetectomy, or foraminotomy (unilateral or bilateral with decompression of spinal cord, cauda equina and/or nerve root[s] [eg, spinal or lateral recess stenosis]), during posterior interbody arthrodesis, lumbar; each additional vertebral segment (List separately in addition to code for primary procedure)


name: Revision or replacement of hypoglossal nerve neurostimulator array and distal respiratory sensor electrode or electrode array, including connection to existing pulse generator


name: Thermal destruction of intraosseous basivertebral nerve, including all imaging guidance; first 2 vertebral bodies, lumbar or sacral


name: Thermal destruction of intraosseous basivertebral nerve, including all imaging guidance; each additional vertebral body, lumbar or sacral (List separately in addition to code for primary procedure)


name: Extracapsular cataract removal with insertion of intraocular lens prosthesis (1-stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification), complex, requiring devices or techniques not generally used in routine cataract surgery (eg, iris expansion device, suture support for intraocular lens, or primary posterior capsulorrhexis) or performed on patients in the amblyogenic developmental stage; with insertion of intraocular (eg, trabecular meshwork, supraciliary, suprachoroidal) anterior segment aqueous drainage device, without extraocular reservoir, internal approach, one or more


name: Extracapsular cataract removal with insertion of intraocular lens prosthesis (1 stage procedure), manual or mechanical technique (eg, irrigation and aspiration or phacoemulsification); with insertion of intraocular (eg, trabecular meshwork, supraciliary, suprachoroidal) anterior segment aqueous drainage device, without extraocular reservoir, internal approach, one or more


name: Insertion of drug-eluting implant, including punctal dilation when performed, into lacrimal canaliculus, each


name: Replacement (including removal of existing device), osseointegrated implant, skull; with magnetic transcutaneous attachment to external speech processor, within the mastoid and/or involving a bony defect less than 100 sq mm surface area of bone deep to the outer cranial cortex


name: Trabecular bone score (TBS), structural condition of the bone microarchitecture; technical preparation and transmission of data for analysis to be performed elsewhere


name: Trabecular bone score (TBS), structural condition of the bone microarchitecture; technical calculation only


name: Pathology clinical consultation; for a clinical problem, with limited review of patient's history and medical records and straightforward medical decision making When using time for code selection, 5-20 minutes of total time is spent on the date of the consultation.


name: Pathology clinical consultation; for a moderately complex clinical problem, with review of patient's history and medical records and moderate level of medical decision making When using time for code selection, 21-40 minutes of total time is spent on the date of the consultation.


name: Pathology clinical consultation; for a highly complex clinical problem, with comprehensive review of patient's history and medical records and high level of medical decision making When using time for code selection, 41-60 minutes of total time is spent on the date of the consultation.


name: Pathology clinical consultation; prolonged service, each additional 30 minutes (List separately in addition to code for primary procedure)


name: Cytogenomic (genome-wide) analysis for constitutional chromosomal abnormalities; interrogation of genomic regions for copy number and loss-of-heterozygosity variants, low-pass sequencing analysis


name: Oncology (breast), mRNA, next-generation sequencing gene expression profiling of 70 content genes and 31 housekeeping genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as index related to risk to distant metastasis


name: Transplantation medicine (allograft rejection, pediatric liver and small bowel), measurement of donor and third-party-induced CD154+T-cytotoxic memory cells, utilizing whole peripheral blood, algorithm reported as a rejection risk score


name: Actin (smooth muscle) antibody (ASMA), each


name: Antineutrophil cytoplasmic antibody (ANCA); screen, each antibody


name: Antineutrophil cytoplasmic antibody (ANCA); titer, each antibody


name: Aquaporin-4 (neuromyelitis optica [NMO]) antibody; enzyme-linked immunosorbent immunoassay (ELISA)


name: Aquaporin-4 (neuromyelitis optica [NMO]) antibody; cell-based immunofluorescence assay (CBA), each


name: Aquaporin-4 (neuromyelitis optica [NMO]) antibody; flow cytometry (ie, fluorescence-activated cell sorting [FACS]), each


name: Endomysial antibody (EMA), each immunoglobulin (Ig) class


name: Gliadin (deamidated) (DGP) antibody, each immunoglobulin (Ig) class


name: Myelin oligodendrocyte glycoprotein (MOG-IgG1) antibody; cell-based immunofluorescence assay (CBA), each


name: Myelin oligodendrocyte glycoprotein (MOG-IgG1) antibody; flow cytometry (ie, fluorescence-activated cell sorting [FACS]), each


name: Tissue transglutaminase, each immunoglobulin (Ig) class


name: Voltage-gated calcium channel antibody, each


name: Culture, typing; identification of blood pathogen and resistance typing, when performed, by nucleic acid (DNA or RNA) probe, multiplexed amplified probe technique including multiplex reverse transcription, when performed, per culture or isolate, 6 or more targets


name: Targeted genomic sequence analysis panel, solid organ neoplasm, cell-free circulating DNA analysis of 55-74 genes, interrogation for sequence variants, gene copy number amplifications, and gene rearrangements


name: Obstetrics (preeclampsia), biochemical assay of placental-growth factor, time-resolved fluorescence immunoassay, maternal serum, predictive algorithm reported as a risk score for preeclampsia


name: Oncology (solid organ), DNA, comprehensive genomic profiling, 257 genes, interrogation for single-nucleotide variants, insertions/deletions, copy number alterations, gene rearrangements, tumor-mutational burden and microsatellite instability, utilizing formalin-fixed paraffin-embedded tumor tissue


name: Oncology (thyroid), mutation analysis of 10 genes and 37 RNA fusions and expression of 4 mRNA markers using next-generation sequencing, fine needle aspirate, report includes associated risk of malignancy expressed as a percentage


name: Red blood cell antigen typing, DNA, genotyping of at least 16 blood groups with phenotype prediction of at least 51 red blood cell antigens


name: Obstetrics (preterm birth), insulin-like growth factor-binding protein 4 (IBP4), sex hormone-binding globulin (SHBG), quantitative measurement by LC-MS/MS, utilizing maternal serum, combined with clinical data, reported as predictive-risk stratification for spontaneous preterm birth


name: Oncology (brain), spheroid cell culture in a 3D microenvironment, 12 drug panel, tumor-response prediction for each drug


name: Oncology (breast), semiquantitative analysis of 32 phosphoproteins and protein analytes, includes laser capture microdissection, with algorithmic analysis and interpretative report


name: Oncology (solid organ neoplasm), targeted genomic sequence DNA analysis of 505 genes, interrogation for somatic alterations (SNVs [single nucleotide variant], small insertions and deletions, one amplification, and four translocations), microsatellite instability and tumor-mutation burden


name: Fetal aneuploidy short tandem-repeat comparative analysis, fetal DNA from products of conception, reported as normal (euploidy), monosomy, trisomy, or partial deletion/duplication, mosaicism, and segmental aneuploidy


name: Reproductive medicine (endometrial receptivity analysis), RNA gene expression profile, 238 genes by next-generation sequencing, endometrial tissue, predictive algorithm reported as endometrial window of implantation (eg, pre-receptive, receptive, post-receptive)


name: Reproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using embryonic DNA genomic sequence analysis for aneuploidy, and a mitochondrial DNA score in euploid embryos, results reported as normal (euploidy), monosomy, trisomy, or partial deletion/duplication, mosaicism, and segmental aneuploidy, per embryo tested


name: Andrology (infertility), sperm-capacitation assessment of ganglioside GM1 distribution patterns, fluorescence microscopy, fresh or frozen specimen, reported as percentage of capacitated sperm and probability of generating a pregnancy score


name: Trimethylamine/trimethylamine N-oxide (TMA/TMAO) profile, tandem mass spectrometry (MS/MS), urine, with algorithmic analysis and interpretive report


name: Very long chain acyl-coenzyme A (CoA) dehydrogenase (VLCAD), leukocyte enzyme activity, whole blood


name: Autoimmune (psoriasis), mRNA, next-generation sequencing, gene expression profiling of 50-100 genes, skin-surface collection using adhesive patch, algorithm reported as likelihood of response to psoriasis biologics


name: Nephrology (chronic kidney disease), nuclear magnetic resonance spectroscopy measurement of myo-inositol, valine, and creatinine, algorithmically combined with cystatin C (by immunoassay) and demographic data to determine estimated glomerular filtration rate (GFR), serum, quantitative


name: Oncology (colorectal cancer), image analysis with artificial intelligence assessment of 4 histologic and immunohistochemical features (CD3 and CD8 within tumor-stroma border and tumor core), tissue, reported as immune response and recurrence-risk score


name: Oncology (solid tumor), gene expression profiling by real-time RT-PCR of 7 gene pathways (ER, AR, PI3K, MAPK, HH, TGFB, Notch), formalin-fixed paraffin-embedded (FFPE), algorithm reported as gene pathway activity score


name: Neurology (autism spectrum disorder [ASD]), quantitative measurements of 16 central carbon metabolites (ie, α-ketoglutarate, alanine, lactate, phenylalanine, pyruvate, succinate, carnitine, citrate, fumarate, hypoxanthine, inosine, malate, S-sulfocysteine, taurine, urate, and xanthine), liquid chromatography tandem mass spectrometry (LC-MS/MS), plasma, algorithmic analysis with result reported as negative or positive (with metabolic subtypes of ASD)


name: Rare constitutional and other heritable disorders, whole genome and mitochondrial DNA sequence analysis, blood, frozen and formalin-fixed paraffin-embedded (FFPE) tissue, saliva, buccal swabs or cell lines, identification of single nucleotide and copy number variants


name: Unexplained constitutional or other heritable disorders or syndromes, tissue-specific gene expression by whole-transcriptome and next-generation sequencing, blood, formalin-fixed paraffin-embedded (FFPE) tissue or fresh frozen tissue, reported as presence or absence of splicing or expression changes


name: Rare constitutional and other heritable disorders, identification of copy number variations, inversions, insertions, translocations, and other structural variants by optical genome mapping and whole genome sequencing


name: Hematology (atypical hemolytic uremic syndrome [aHUS]), genomic sequence analysis of 15 genes, blood, buccal swab, or amniotic fluid


name: Hematology (autosomal dominant congenital thrombocytopenia), genomic sequence analysis of 14 genes, blood, buccal swab, or amniotic fluid


name: Hematology (congenital coagulation disorders), genomic sequence analysis of 20 genes, blood, buccal swab, or amniotic fluid


name: Hematology (congenital neutropenia), genomic sequence analysis of 23 genes, blood, buccal swab, or amniotic fluid


name: Hematology (genetic bleeding disorders), genomic sequence analysis of 51 genes, blood, buccal swab, or amniotic fluid, comprehensive


name: Hematology (genetic hyperfibrinolysis, delayed bleeding), analysis of 9 genes (F13A1, F13B, FGA, FGB, FGG, SERPINA1, SERPINE1, SERPINF2 by next-generation sequencing, and PLAU by array comparative genomic hybridization), blood, buccal swab, or amniotic fluid


name: Hematology (genetic platelet disorders), genomic sequence analysis of 43 genes, blood, buccal swab, or amniotic fluid


name: Hematology (heparin-induced thrombocytopenia), platelet antibody reactivity by flow cytometry, serum


name: Hematology (inherited thrombocytopenia), genomic sequence analysis of 42 genes, blood, buccal swab, or amniotic fluid


name: Hematology (genetic platelet function disorder), genomic sequence analysis of 31 genes, blood, buccal swab, or amniotic fluid


name: Hematology (genetic thrombosis), genomic sequence analysis of 12 genes, blood, buccal swab, or amniotic fluid


name: Hematology (von Willebrand disease [VWD]), von Willebrand factor (VWF) and collagen III binding by enzyme-linked immunosorbent assays (ELISA), plasma, report of collagen III binding


name: Hematology (von Willebrand disease [VWD]), von Willebrand factor (VWF) and collagen IV binding by enzyme-linked immunosorbent assays (ELISA), plasma, report of collagen IV binding


name: Hematology (von Willebrand disease [VWD]), von Willebrand propeptide, enzyme-linked immunosorbent assays (ELISA), plasma, diagnostic report of von Willebrand factor (VWF) propeptide antigen level


name: Red blood cell antigen typing, DNA, genotyping of 12 blood group system genes to predict 44 red blood cell antigen phenotypes


name: von Willebrand factor (VWF), type 2B, platelet-binding evaluation, radioimmunoassay, plasma


name: von Willebrand factor (VWF), type 2N, factor VIII and VWF binding evaluation, enzyme-linked immunosorbent assays (ELISA), plasma


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; third dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; third dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x1010 viral particles/0.5 mL dosage; first dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x1010 viral particles/0.5 mL dosage; second dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x1010 viral particles/0.5 mL dosage; single dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5 mL dosage; first dose


name: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5 mL dosage; second dose


name: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x1010 viral particles/0.5 mL dosage, for intramuscular use


name: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x1010 viral particles/0.5 mL dosage, for intramuscular use


name: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5 mL dosage, for intramuscular use


name: Pneumococcal conjugate vaccine, 15 valent (PCV15), for intramuscular use


name: Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use


name: Tick-borne encephalitis virus vaccine, inactivated; 0.25 mL dosage, for intramuscular use


name: Tick-borne encephalitis virus vaccine, inactivated; 0.5 mL dosage, for intramuscular use


name: Hepatitis B vaccine (HepB), 3-antigen (S, Pre-S1, Pre-S2), 10 mcg dosage, 3 dose schedule, for intramuscular use


name: Zaire ebolavirus vaccine, live, for intramuscular use


name: 3D echocardiographic imaging and postprocessing during transesophageal echocardiography, or during transthoracic echocardiography for congenital cardiac anomalies, for the assessment of cardiac structure(s) (eg, cardiac chambers and valves, left atrial appendage, interatrial septum, interventricular septum) and function, when performed (List separately in addition to code for echocardiographic imaging)


name: Right heart catheterization for congenital heart defect(s) including imaging guidance by the proceduralist to advance the catheter to the target zone; normal native connections


name: Right heart catheterization for congenital heart defect(s) including imaging guidance by the proceduralist to advance the catheter to the target zone; abnormal native connections


name: Left heart catheterization for congenital heart defect(s) including imaging guidance by the proceduralist to advance the catheter to the target zone, normal or abnormal native connections


name: Right and left heart catheterization for congenital heart defect(s) including imaging guidance by the proceduralist to advance the catheter to the target zone(s); normal native connections


name: Right and left heart catheterization for congenital heart defect(s) including imaging guidance by the proceduralist to advance the catheter to the target zone(s); abnormal native connections


name: Cardiac output measurement(s), thermodilution or other indicator dilution method, performed during cardiac catheterization for the evaluation of congenital heart defects (List separately in addition to code for primary procedure)


name: Physician or other qualified health care professional services for outpatient pulmonary rehabilitation; without continuous oximetry monitoring (per session)


name: Physician or other qualified health care professional services for outpatient pulmonary rehabilitation; with continuous oximetry monitoring (per session)


name: Remote therapeutic monitoring (eg, therapy adherence, therapy response); initial set-up and patient education on use of equipment


name: Remote therapeutic monitoring (eg, therapy adherence, therapy response); device(s) supply with scheduled (eg, daily) recording(s) and/or programmed alert(s) transmission to monitor respiratory system, each 30 days


name: Remote therapeutic monitoring (eg, therapy adherence, therapy response); device(s) supply with scheduled (eg, daily) recording(s) and/or programmed alert(s) transmission to monitor musculoskeletal system, each 30 days


name: Remote therapeutic monitoring treatment management services, physician or other qualified health care professional time in a calendar month requiring at least one interactive communication with the patient or caregiver during the calendar month; first 20 minutes


name: Remote therapeutic monitoring treatment management services, physician or other qualified health care professional time in a calendar month requiring at least one interactive communication with the patient or caregiver during the calendar month; each additional 20 minutes (List separately in addition to code for primary procedure)


name: Insertion of anterior segment aqueous drainage device into the trabecular meshwork, without external reservoir, and without concomitant cataract removal, one or more


name: Noncontact near-infrared spectroscopy studies of flap or wound (eg, for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation [StO2]); image acquisition, interpretation and report, each flap or wound


name: Noncontact near-infrared spectroscopy studies of flap or wound (eg, for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation [StO2]); image acquisition only, each flap or wound


name: Noncontact near-infrared spectroscopy studies of flap or wound (eg, for measurement of deoxyhemoglobin, oxyhemoglobin, and ratio of tissue oxygenation [StO2]); interpretation and report only, each flap or wound


name: Transcatheter left ventricular restoration device implantation including right and left heart catheterization and left ventriculography when performed, arterial approach


name: Transcatheter tricuspid valve implantation (TTVI)/replacement with prosthetic valve, percutaneous approach, including right heart catheterization, temporary pacemaker insertion, and selective right ventricular or right atrial angiography, when performed


name: Transcatheter removal or debulking of intracardiac mass (eg, vegetations, thrombus) via suction (eg, vacuum, aspiration) device, percutaneous approach, with intraoperative reinfusion of aspirated blood, including imaging guidance, when performed


name: Transcatheter implantation of coronary sinus reduction device including vascular access and closure, right heart catheterization, venous angiography, coronary sinus angiography, imaging guidance, and supervision and interpretation, when performed


name: Insertion of gastrostomy tube, percutaneous, with magnetic gastropexy, under ultrasound guidance, image documentation and report


name: Quantitative magnetic resonance for analysis of tissue composition (eg, fat, iron, water content), including multiparametric data acquisition, data preparation and transmission, interpretation and report, obtained without diagnostic MRI examination of the same anatomy (eg, organ, gland, tissue, target structure) during the same session; single organ


name: Quantitative magnetic resonance for analysis of tissue composition (eg, fat, iron, water content), including multiparametric data acquisition, data preparation and transmission, interpretation and report, obtained without diagnostic MRI examination of the same anatomy (eg, organ, gland, tissue, target structure) during the same session; multiple organs


name: Quantitative magnetic resonance for analysis of tissue composition (eg, fat, iron, water content), including multiparametric data acquisition, data preparation and transmission, interpretation and report, obtained with diagnostic MRI examination of the same anatomy (eg, organ, gland, tissue, target structure); single organ (List separately in addition to code for primary procedure)


name: Quantitative magnetic resonance for analysis of tissue composition (eg, fat, iron, water content), including multiparametric data acquisition, data preparation and transmission, interpretation and report, obtained with diagnostic MRI examination of the same anatomy (eg, organ, gland, tissue, target structure); multiple organs (List separately in addition to code for primary procedure)


name: Programming device evaluation (remote) of subcutaneous cardiac rhythm monitor system, with iterative adjustment of the implantable device to test the function of the device and select optimal permanently programmed values with analysis, review and report by a physician or other qualified health care professional


name: Magnetically controlled capsule endoscopy, esophagus through stomach, including intraprocedural positioning of capsule, with interpretation and report


name: Esophagogastroduodenoscopy, flexible, transnasal; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)


name: Esophagogastroduodenoscopy, flexible, transnasal; with biopsy, single or multiple


name: Esophagogastroduodenoscopy, flexible, transnasal; with insertion of intraluminal tube or catheter


name: Transperineal focal laser ablation of malignant prostate tissue, including transrectal imaging guidance, with MR-fused images or other enhanced ultrasound imaging


name: Electrical impedance spectroscopy of 1 or more skin lesions for automated melanoma risk score


name: Transcatheter intracoronary infusion of supersaturated oxygen in conjunction with percutaneous coronary revascularization during acute myocardial infarction, including catheter placement, imaging guidance (eg, fluoroscopy), angiography, and radiologic supervision and interpretation


name: Removal and reimplantation of anterior segment intraocular nonbiodegradable drug-eluting implant


name: Scalp cooling, mechanical; initial measurement and calibration of cap


name: Scalp cooling, mechanical; placement of device, monitoring, and removal of device (List separately in addition to code for primary procedure)


name: Donor hysterectomy (including cold preservation); open, from cadaver donor


name: Donor hysterectomy (including cold preservation); laparoscopic or robotic, from living donor


name: Donor hysterectomy (including cold preservation); recipient uterus allograft transplantation from cadaver or living donor


name: Backbench standard preparation of cadaver or living donor uterine allograft prior to transplantation, including dissection and removal of surrounding soft tissues and preparation of uterine vein(s) and uterine artery(ies), as necessary


name: Backbench reconstruction of cadaver or living donor uterus allograft prior to transplantation; venous anastomosis, each


name: Backbench reconstruction of cadaver or living donor uterus allograft prior to transplantation; arterial anastomosis, each


name: Endovaginal cryogen-cooled, monopolar radiofrequency remodeling of the tissues surrounding the female bladder neck and proximal urethra for urinary incontinence


name: Ablation, benign thyroid nodule(s), percutaneous, laser, including imaging guidance


name: Laparoscopic insertion of new or replacement of permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function, including an implantable pulse generator and diaphragmatic lead(s)


name: Laparoscopic insertion of new or replacement of diaphragmatic lead(s), permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function, including connection to an existing pulse generator; first lead


name: Laparoscopic insertion of new or replacement of diaphragmatic lead(s), permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function, including connection to an existing pulse generator; each additional lead (List separately in addition to code for primary procedure)


name: Laparoscopic repositioning of diaphragmatic lead(s), permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function, including connection to an existing pulse generator; first repositioned lead


name: Laparoscopic repositioning of diaphragmatic lead(s), permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function, including connection to an existing pulse generator; each additional repositioned lead (List separately in addition to code for primary procedure)


name: Laparoscopic removal of diaphragmatic lead(s), permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function


name: Insertion or replacement of pulse generator only, permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function, with connection to existing lead(s)


name: Relocation of pulse generator only, permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function, with connection to existing dual leads


name: Removal of pulse generator only, permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function


name: Programming device evaluation (in-person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional, permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function


name: Peri-procedural device evaluation (in-person) and programming of device system parameters before or after a surgery, procedure, or test with analysis, review, and report by a physician or other qualified health care professional, permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function


name: Interrogation device evaluation (in-person) with analysis, review and report by a physician or other qualified health care professional, including connection, recording and disconnection per patient encounter, permanent implantable synchronized diaphragmatic stimulation system for augmentation of cardiac function


name: Histotripsy (ie, non-thermal ablation via acoustic energy delivery) of malignant hepatocellular tissue, including image guidance


name: Treatment of amblyopia using an online digital program; device supply, educational set-up, and initial session


name: Treatment of amblyopia using an online digital program; assessment of patient performance and program data by physician or other qualified health care professional, with report, per calendar month


name: Quantitative ultrasound tissue characterization (non-elastographic), including interpretation and report, obtained without diagnostic ultrasound examination of the same anatomy (eg, organ, gland, tissue, target structure)


name: Quantitative ultrasound tissue characterization (non-elastographic), including interpretation and report, obtained with diagnostic ultrasound examination of the same anatomy (eg, organ, gland, tissue, target structure) (List separately in addition to code for primary procedure)


name: Automated analysis of an existing computed tomography study for vertebral fracture(s), including assessment of bone density when performed, data preparation, interpretation, and report


name: 3-dimensional volumetric imaging and reconstruction of breast or axillary lymph node tissue, each excised specimen, 3-dimensional automatic specimen reorientation, interpretation and report, real-time intraoperative


name: Body surface-activation mapping of pacemaker or pacing cardioverter-defibrillator lead(s) to optimize electrical synchrony, cardiac resynchronization therapy device, including connection, recording, disconnection, review, and report; at time of implant or replacement


name: Body surface-activation mapping of pacemaker or pacing cardioverter-defibrillator lead(s) to optimize electrical synchrony, cardiac resynchronization therapy device, including connection, recording, disconnection, review, and report; at time of follow-up interrogation or programming device evaluation


name: Molecular fluorescent imaging of suspicious nevus; first lesion


name: Molecular fluorescent imaging of suspicious nevus; each additional lesion (List separately in addition to code for primary procedure)


name: Remote treatment of amblyopia using an eye tracking device; device supply with initial set-up and patient education on use of equipment


name: Remote treatment of amblyopia using an eye tracking device; surveillance center technical support including data transmission with analysis, with a minimum of 18 training hours, each 30 days


name: Remote treatment of amblyopia using an eye tracking device; interpretation and report by physician or other qualified health care professional, per calendar month


name: Injection(s), bone-substitute material (eg, calcium phosphate) into subchondral bone defect (ie, bone marrow lesion, bone bruise, stress injury, microtrabecular fracture), including imaging guidance and arthroscopic assistance for joint visualization


name: Intradermal cancer immunotherapy; each additional injection (List separately in addition to code for primary procedure)


name: Noninvasive arterial plaque analysis using software processing of data from non-coronary computerized tomography angiography; including data preparation and transmission, quantification of the structure and composition of the vessel wall and assessment for lipid-rich necrotic core plaque to assess atherosclerotic plaque stability, data review, interpretation and report


name: Noninvasive arterial plaque analysis using software processing of data from non-coronary computerized tomography angiography; data preparation and transmission


name: Noninvasive arterial plaque analysis using software processing of data from non-coronary computerized tomography angiography; quantification of the structure and composition of the vessel wall and assessment for lipid-rich necrotic core plaque to assess atherosclerotic plaque stability


name: Noninvasive arterial plaque analysis using software processing of data from non-coronary computerized tomography angiography; data review, interpretation and report


name: Oncology (diffuse large B-cell lymphoma [DLBCL]), mRNA, gene expression profiling by fluorescent probe hybridization of 20 genes, formalin-fixed paraffin-embedded tissue, algorithm reported as cell of origin


name: Transplantation medicine (allograft rejection, renal), measurement of donor and third-party-induced CD154+T-cytotoxic memory cells, utilizing whole peripheral blood, algorithm reported as a rejection risk score


name: New patient office or other outpatient visit, 15-29 minutes


name: New patient office or other outpatient visit, 30-44 minutes


name: New patient office or other outpatient visit, 45-59 minutes


name: New patient office or other outpatient visit, 60-74 minutes


name: Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional


name: Established patient office or other outpatient visit, 10-19 minutes


name: Established patient office or other outpatient visit, 20-29 minutes


name: Established patient office or other outpatient visit, 30-39 minutes


name: Established patient office or other outpatient visit, 40-54 minutes


name: Critical care, each additional 30 minutes


name: Extended patient service without direct patient contact, first hour


name: Extended patient service without direct patient contact, each additional 30 minutes


name: Extended office or other outpatient service by clinical staff, first hour


name: Extended office or other outpatient service by clinical staff, each additional 30 minutes


name: Extended physician standby service, each 30 minutes


name: Initial new patient preventive medicine evaluation (younger than 1 year)


name: Initial new patient preventive medicine evaluation (1-4 years)


name: Initial new patient preventive medicine evaluation (5-11 years)


name: Initial new patient preventive medicine evaluation (12-17 years)


name: Initial new patient preventive medicine evaluation (18-39 years)


name: Initial new patient preventive medicine evaluation (40-64 years)


name: Initial new patient preventive medicine evaluation (65 years or older)


name: Established patient periodic preventive medicine examination (younger than 1 year)


name: Established patient periodic preventive medicine examination (1-4 years)


name: Established patient periodic preventive medicine examination (5-11 years)


name: Established patient periodic preventive medicine examination (12-17 years)


name: Established patient periodic preventive medicine examination (18-39 years)


name: Established patient periodic preventive medicine examination (40-64 years)


name: Established patient periodic preventive medicine examination (65 year old or older)


name: Preventive medicine counseling, typically 15 minutes


name: Preventive medicine counseling, typically 30 minutes


name: Preventive medicine counseling, typically 45 minutes


name: Preventive medicine counseling, typically 1 hour


name: Smoking and tobacco use intensive counseling, 4-10 minutes


name: Smoking and tobacco use intensive counseling, more than 10 minutes


name: Alcohol and/or substance abuse screening and intervention, more than 30 minutes


name: Group preventive medicine counseling, typically 30 minutes


name: Group preventive medicine counseling, typically 1 hour


name: Telephone medical discussion with physician, 5-10 minutes


name: Telephone medical discussion with physician, 11-20 minutes


name: Telephone medical discussion with physician, 21-30 minutes


name: Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes


name: Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes


name: Online digital evaluation and management service for an established patient for up to 7 days, total time 21 or more minutes


name: Telephone or internet assessment with verbal and written report by consulting physician, 11-20 minutes


name: Telephone or internet assessment with verbal and written report by consulting physician, 21-30 minutes


name: Telephone or internet assessment with verbal and written report by consulting physician, more than 30 minutes


name: Education and training to self measure blood pressure


name: Management using the results of remote vital sign monitoring per calendar month, first 20 minutes


name: Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes


name: Initial evaluation and management of newborn per day


name: Initial evaluation and management of newborn not in hospital or birthing center per day


name: Follow-up hospital care of newborn per day


name: Critical care during transport between facilities, first 30-74 minutes (2 years or younger)


name: Critical care during transport between facilities, each additional 30 minutes (2 years or younger)


name: Supervision of interfacility transport care of critical patient, first 30 minutes (2 years or younger)


name: Supervision of interfacility transport care of critical patient, each additional 30 minutes (2 years or younger)


name: Initial inpatient hospital critical care of newborn per day (28 days or younger)


name: Follow-up inpatient hospital critical care of newborn per day (28 days or younger)


name: Initial inpatient hospital critical care of infant or young child per day (29 days to 2 years)


name: Follow-up inpatient hospital critical care of infant or young child per day (29 days to 2 years)


name: Initial inpatient hospital critical care of infant or young child per day (2-5 years)


name: Follow-up inpatient hospital critical care of infant or young child per day (2-5 years)


name: Initial intensive care of newborn per day (28 days or younger)


name: Follow-up intensive care of recovering very low birth weight infant per day


name: Follow-up intensive care of recovering low birth weight infant per day


name: Follow-up intensive care of recovering medium birth weight infant per day


name: Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month


name: Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month


name: Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month


name: Chronic care management services for two or more chronic conditions, additional 30 minutes provided personally by health care professional, per calendar month


name: Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month


name: Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month


name: Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month.


name: Principal care management services for a single high-risk disease, each additional 30 minutes provided personally by qualified health care professional, per calendar month


name: Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month


name: Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month


name: Follow-up psychiatric collaborative care management, subsequent calendar month, first 60 minutes


name: Psychiatric collaborative care management per calendar month, each additional 30 minutes


name: Transitional care management services for problem of high complexity


name: Advance care planning, each additional 30 minutes


name: Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional


name: Anesthesia for procedure on saliva gland


name: Anesthesia for plastic repair of lip defect


name: Anesthesia for exam of ear using an endoscope


name: Anesthesia for exam of inner eye using an endoscope


name: Anesthesia for other procedure on nose and sinuses


name: Anesthesia for extensive surgery on nose and sinuses


name: Anesthesia for extensive surgery on mouth


name: Anesthesia for other procedure on face bones or skull


name: Anesthesia for extensive surgery on face bones or skull


name: Anesthesia for removal of blood collection from brain


name: Anesthesia for removal of fluid from brain


name: Anesthesia for procedure on brain while sitting up


name: Anesthesia for other procedure on skin, muscles, or nerves of head, neck, and upper back


name: Anesthesia for other procedure on neck area (1 year or older)


name: Anesthesia for other procedure on neck area (younger than 1 year)


name: Anesthesia for other procedure on large blood vessel of neck


name: Anesthesia for tying large blood vessels of neck


name: Anesthesia for other procedure on skin of arms, legs, and front body


name: Anesthesia for removal of all or part of breast


name: Anesthesia for other procedure on collar bone and shoulder blade


name: Anesthesia for other partial removal of rib


name: Anesthesia for extensive partial removal of rib


name: Anesthesia for closed exam of chest using an endoscope


name: Anesthesia for closed exam of chest using an endoscope with 1 lung inflated


name: Anesthesia for procedure to assess heart electrical activity


name: Anesthesia for procedure on chest with 1 lung inflated


name: Anesthesia for removal of tissue from around lung


name: Anesthesia for procedure on heart and large blood vessels


name: Anesthesia for procedure on heart and large blood vessels using heart-lung machine (younger than 1 year)


name: Anesthesia for procedure on heart and large blood vessels using heart-lung machine (1 year or older)


name: Anesthesia for procedure on heart and large blood vessels using heart-lung machine and stopping blood flow


name: Anesthesia for other procedure on upper spine


name: Anesthesia for procedure on upper spine with sitting up


name: Anesthesia for other procedure on middle spine


name: Anesthesia for procedure on middle spine through chest wall


name: Anesthesia for procedure on middle spine through chest wall with 1 lung inflated


name: Anesthesia for other procedure on lower spine


name: Anesthesia for manipulation or closed procedure of spine


name: Anesthesia for extensive surgery on spine


name: Anesthesia for other procedure on upper front abdomen


name: Anesthesia for procedure on upper rear abdomen


name: Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope


name: Anesthesia for procedure on gallbladder, pancreas, or liver using an endoscope


name: Anesthesia for other repair of upper abdomen hernia


name: Anesthesia for procedure on large blood vessels in abdomen


name: Anesthesia for other procedure on upper abdomen


name: Anesthesia for procedure on stomach for weight loss


name: Anesthesia for other procedure on lower front abdomen


name: Anesthesia for removal of excess tissue of lower rear abdomen


name: Anesthesia for other procedure on large bowel using an endoscope


name: Anesthesia for exam of colon using an endoscope


name: Anesthesia for procedure on small and large bowel using an endoscope


name: Anesthesia for procedure on lower rear abdomen


name: Anesthesia for other repair of lower abdomen hernia (1 year or older)


name: Anesthesia for repair of abdominal wall hernia


name: Anesthesia for other repair of lower abdomen hernia (younger than 1 year)


name: Anesthesia for repair of lower abdomen hernia (infant younger than 37 weeks at birth and younger than 50 weeks of age at time of surgery)


name: Anesthesia for other procedure on lower abdomen


name: Anesthesia for removal of amniotic fluid from uterus


name: Anesthesia for other procedure on lower abdomen outside abdominal cavity


name: Anesthesia for procedure on upper urinary tubes or removal of kidney for transplant


name: Anesthesia for extensive removal of prostate


name: Anesthesia for other procedure on large blood vessel of lower abdomen


name: Anesthesia for tying of large vein of lower abdomen


name: Anesthesia for extensive procedure on perineum


name: Anesthesia for removal of external female genitals


name: Anesthesia for other procedure on urinary system through urethra


name: Anesthesia for other procedure on male genitals


name: Anesthesia for procedure on male genital glands


name: Anesthesia for procedure on undescended testicle


name: Anesthesia for removal of testicle through incision in abdomen


name: Anesthesia for amputation of penis and removal of lymph nodes of groin


name: Anesthesia for other procedure on female genitals


name: Anesthesia for exam of cervix using an endoscope


name: Anesthesia for exam of uterus using an endoscope


name: Anesthesia for extensive removal of growth of hip bone


name: Anesthesia for closed procedure on pubic bone or pelvic joint


name: Anesthesia for procedure on pubic bone or pelvic joint


name: Anesthesia for repair of broken hip bone


name: Anesthesia for other procedure on hip joint


name: Anesthesia for removal of hip bone at joint


name: Anesthesia for revision of total hip replacement


name: Anesthesia for closed procedure on upper 2/3rd of thigh bone


name: Anesthesia for procedure on upper 2/3rd of thigh bone